Edition:
India

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

11.40USD
19 Jan 2018
Change (% chg)

$0.40 (+3.64%)
Prev Close
$11.00
Open
$10.90
Day's High
$11.50
Day's Low
$10.90
Volume
97,964
Avg. Vol
155,303
52-wk High
$13.15
52-wk Low
$4.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 6.70 -0.583
Jun '17 4.91 -0.826
Mar '17 5.63 -0.871
FY 2016 Dec '16 3.50 -1.144
Sep '16 1.58 -1.606
Jun '16 1.49 -1.654
Mar '16 2.58 -0.787
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 14.00 14.00 14.00 --
Quarter Ending Jun-18 1 17.20 17.20 17.20 --
Year Ending Dec-18 6 67.52 84.00 50.00 107.97
Earnings (per share)
Quarter Ending Mar-18 1 -0.47 -0.47 -0.47 --
Quarter Ending Jun-18 1 -0.40 -0.40 -0.40 --
Year Ending Dec-18 6 -1.54 -1.15 -2.03 -0.79
LT Growth Rate (%) 2 66.10 90.00 42.20 90.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta -- 0.90 0.89
Price to Sales (TTM) 16.36 3.98 5.45
Price to Book (MRQ) 9.83 4.82 5.38
Price to Tangible Book (MRQ) 30.29 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 54.15 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 230.57 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 162.64 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 50.06 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -18.09 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.84 2.11 2.18
Current Ratio (MRQ) 3.04 2.88 2.97
LT Debt to Equity (MRQ) 233.06 9.81 12.10
Total Debt to Equity (MRQ) 260.80 13.80 16.38
Interest Coverage (TTM) -7.98 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 12.84 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -441.05 -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) -460.09 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) -511.73 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) -511.73 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 116,582 948,195,516 855,725,045
Net Income/Employee (TTM) -596,590 111,561,295 100,665,187
Receivable Turnover (TTM) 2.76 5.61 5.76
Inventory Turnover (TTM) 2.59 2.57 3.34
Asset Turnover (TTM) 0.13 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.73 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -84.78 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -242.19 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 141.40 106.21 --
EPS (TTM) % -150.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Neos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.64%
# of Holders: 98
Total Shares Held: 16,424,467
3 Mo. Net Change: 393,088
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 3
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.